Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-PD-1 nanobody PD-1/nb18 and its preparation method and application

A nano-antibody and PD-1 technology, which is applied in the fields of botany equipment and methods, biochemical equipment and methods, antibodies, etc., can solve the problems of high production cost, poor stability and easy degradation, long development cycle, etc.

Active Publication Date: 2020-08-18
GUANGXI MEDICAL UNIVERSITY
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, there are many problems in the application of antibody drugs, such as long research and development cycle, high production cost, difficulty in large-scale production, poor stability and easy degradation, high storage cost, easy contamination, high maintenance cost, and immunogenicity, etc. its scope of clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-PD-1 nanobody PD-1/nb18 and its preparation method and application
  • Anti-PD-1 nanobody PD-1/nb18 and its preparation method and application
  • Anti-PD-1 nanobody PD-1/nb18 and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] Embodiment 1, the preparation of nanobody

[0075] The present invention provides a nanobody derived from camels, its name is PD-1 / Nb18, the amino acid sequence of the nanobody PD-1 / Nb18 is shown in SEQ ID No.8 in the sequence listing, represented by SEQ ID No. 9 nucleotide sequence encoding.

[0076] The nucleotide electrophoresis pattern of nanobody PD-1 / Nb18 is as follows figure 1 As shown, the first channel is a 2000bp molecular marker, the second channel is a PCR product, and the PCR product band is about 400bp.

[0077] Replace the DNA fragment between the PstI and NotI recognition sequences of the vector pComb3 (Biovector product) with the DNA molecule shown in SEQID No.9, and keep the other sequences unchanged to obtain the recombinant vector pComb3-PD-1 / Nb18, pComb3-PD- The only difference between 1 / Nb18 and pComb3 is that the DNA segment between the PstI and NotI recognition sequences of pComb3 is replaced by the DNA molecule shown in SEQ ID No.9. The reco...

Embodiment 2

[0085] Example 2, Determination of the Binding Rate of Nanobody PD-1 / Nb18 and PD-1

[0086] Determination of the binding rate of nanobody PD-1 / Nb18 to PD-1 (direct method)

[0087] 293T cells stably transfected with PD-1 were used to detect the binding rate of nanobody PD-1 / Nb18 to PD-1, and the nanobody PD-1 / Nb18 (1 μg) in Example 1 was added to 1-6×10 6 The above-mentioned 293T cells were incubated at 4°C in the dark for 20-40min, washed twice with PBS, added 5 μl PE anti-HA tag antibody (abcam, Clone: ​​20B12) and incubated at 4°C for 20-40min, washed twice with PBS, and the samples were On the BACKMAN flow cytometer, the results are as follows Figure 3B As shown, 293T cells not transfected with PD-1 were used as a control such as Figure 3A shown. Figure 3A is the binding percentage of blank control and PD-1 Nanobody PD-1 / Nb18 to 293T cells not transfected with PD-1; Figure 3B is the binding percentage of blank control and PD-1 nanobody PD-1 / Nb18 respectively stably...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a PD-1 resistance nanobody PD-1 / Nb18 as well as a preparation method and application thereof. The nanobody PD-1 / Nb18 provided by the invention comprises an antigenic determinant complementary region and a skeleton region; and the antigenic determinant complementary region of the nanobody PD-1 / Nb18 is composed of CDR1, CDR2 and CDR3. Through a nanobody PD-1 / Nb18 nucleotide sequence and a host cell disclosed by the invention, the nanobody PD-1 / Nb18 can be efficiently expressed in Escherichia coli, is applied to development of PD-1 molecular detection reagents and is usedfor preparing a tumor inhibitor or a tumor cell inhibitor and preparing a drug for inhibiting the PD-1 activity and promoting multiplication of T cells.

Description

technical field [0001] The invention relates to anti-PD-1 nanobody PD-1 / Nb18 in the field of biomedicine and its preparation method and application. Background technique [0002] Programmed death receptor 1 (programmed death 1, PD-1) is a transmembrane glycoprotein molecule expressed on the surface of activated T cells, which is a member of the CD28 superfamily and negatively regulates the proliferation of T cells. play an important regulatory role. PD-1 is mainly expressed in activated T cells and B cells, and is a surface receptor of activated T cells. PD-1 has two ligands, programmed cell death-ligand 1 (PD-L1, Also known as B7-H1) and programmed cell death-ligand 1 (PD-L2, also known as B7-DC). The tumor microenvironment in the body will induce infiltrating T cells to highly express PD-1 molecules, and tumor cells will highly express PD-1 ligands PD-L1 and PD-L2, resulting in the continuous activation of PD-1 pathway in the tumor microenvironment. After -L1 is combine...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/28C12N15/13A61K39/395A61P35/00
CPCC07K16/2818C07K2317/569C07K2317/92
Inventor 卢小玲莫凤珍汤卓然
Owner GUANGXI MEDICAL UNIVERSITY